Search BioPortfolio:
BioPortfolio
Web
Home
Marketing Services
News
Reports
Company Profiles
InDepth
Drug Discovery
Careers
Conferences
Videos
Search
Contact
Items Ordered:
Cart Value:
New Products:
1.
The Rise of Mid-Sized Pharma
2.
Contract Research Annual Review 2008
3.
Amgen - The Biotech Leader - Market Analyses and Outlook, 2008-2023
4.
The World OTC Pharmaceutical Market Analysis and Forecasts, 2008-2023
5.
Monoclonal Antibodies Report: 2008 Update
6.
Pipeline and Commercial Insight: Neuropathic Pain - UCB's Vimpat set to compete with major players
7.
Stakeholder Opinions: Non-hormonal Treatments for Menopausal Symptoms - Market open to takers as tepid pipeline fails to meet demand
8.
Rx-to-OTC Strategies: Maximizing the Commercial Potential of an Rx-to-OTC Switch
9.
Drug Repositioning Strategies - Serendipity by design
10.
Forecast Insight: Osteoarthritis - The COX-2 pipeline collapses
Best Sellers:
1.
BioNewsCast Press Release Distribution Service
2.
Immunogenicity to Biologics Implications of reactions against biotech drugs
3.
Outsourcing in Drug Discovery, 3rd Edition
4.
American Hospital Register
5.
Professional Designation in Biopharmaceutical Technology - 3 Course Curriculum
6.
Outlook for RNAi, 2007 - siRNA and miRNA in biology, diagnostics and therapeutics
OEM Contract Manufacturing in Medical Devices Vol I Materials Processing
The world market for OEM Contracting in the Manufacturing of Medical Devices is exploding as original equipment manufacturers are finding new opportunities with managers located at the corporate headquarters or main manufacturing/assembly operations continually reviewing manufacturing costs and looking to outsourcing for cost efficiency.
Kalorama's OEM Contract Manufacturing in Medical Devices Series presents a total study of market for outsourcing in medical devices. It features an exhaustive three-way market segmentation: It looks at the OEM market revenues by therapeutic area, as well as by segment of device manufacturing. And it also includes revenues by the general device classifications (commodity/non-commodity). This allows those looking at this growing market to get a complete picture of the OEM market.
In Vol. I, Materials Processing , markets are analyzed by the following therapeutic areas:
Cardiovascular
General Surgery
Imaging
I.V. Diagnostics
Ophthalmology
Orthopedics
Respiratory
Neurology
Urology
and the following materials processing sectors:
Material Handling and Packaging Equipment
Materials, Chemicals and Adhesives
Metal Fabrication and Metal Injection Molding
Plastic Extrusions
Plastic Moldings
Flow Control and Fluid Transfer
Fluid Power Components
Sterilization Processes
Revenues are also provided for the following general classification of medical devices:
Commodity
Non-Commodity
For each segment, this Kalorama Information study gives current size data and forecasts to 2011, with compound annual growth rates provided for the 2006 to 2011 market period. In addition this exhaustive market analysis, Kalorama Information study reviews Original Equipment Manufacturing Companies (OEMs), and their key capabilities and products, provides an overview of the general medical device market which builds the foundation for O.E.M. potential, and looks at issues and trends in O.E.M. for device manufacturing.
A truly worldwide study, current revenues and forecasts in all therapeutic areas and material processing sectors are provided for U.S., European, Asian, ROW and Global markets.
Published: Aug, 1 2007
Pages: 247
PDF Format
Table of Contents
Price: $3,495.00 / GBP1,747.50
Buy Biotechnology Management Reports online with BioPortfolio's secure E-Commerce portal.